How to Prevent Vaginal Atrophy With or Without Hormones

Vaginal atrophy is both preventable and treatable, whether or not you use hormones. The condition affects roughly half to three-quarters of postmenopausal women, yet many go years without addressing it because they assume it is an inevitable part of aging or feel uncomfortable raising it with a doctor. In reality, a range of options exists, from local estrogen creams and vaginal DHEA to over-the-counter hyaluronic acid gels, pelvic floor exercises, and even laser treatments. Choosing the right strategy depends on your symptoms, your medical history, and how much upkeep you are willing to do.

What Actually Happens to Vaginal Tissue After Menopause

When estrogen levels drop, the vaginal lining thins, loses elasticity, and produces less moisture. The tissue becomes pale, fragile, and more prone to small tears. Vaginal pH rises from its healthy acidic range into more alkaline territory, which shifts the bacterial balance and raises the risk of urinary tract infections.¹ Common symptoms include dryness, burning, itching, pain during sex, and sometimes light spotting or urinary discomfort.²

Animal research has shown that estrogen withdrawal triggers a cascade at the cellular level: nitric oxide synthase enzymes decline, programmed cell death ramps up, collagen accumulates inside vaginal walls, and blood vessel walls thicken.³ In plain terms, the tissue shrinks, stiffens, and loses its blood supply. These changes do not arrive all at once. A large observational study found that about a fifth of women in their early forties already show signs of atrophy, and the proportion climbs to over half by the mid-fifties.⁴ Another multicenter study reported that roughly four out of five women within six years of menopause met diagnostic criteria for the condition.⁵

The clinical term has shifted in recent years from “vaginal atrophy” to “genitourinary syndrome of menopause” (GSM), which better captures the fact that symptoms extend beyond the vagina to include urinary changes. Either way, the underlying driver is the same: estrogen loss. That understanding is what makes hormonal treatments so effective and also why non-hormonal approaches need to work through different pathways.

Local Estrogen Therapy

If you have no medical reason to avoid estrogen, low-dose vaginal estrogen is the most studied and most effective way to reverse atrophy. Applied directly to the tissue as a cream, tablet, or ring, it restores thickness, elasticity, and moisture to the vaginal lining while lowering pH back toward its pre-menopausal acidic range.⁶ Clinical trials comparing the vaginal ring to the vaginal tablet found no difference between the two in symptom relief; both shifted vaginal cell composition from atrophic to proliferative within about a year.⁷

A common worry is whether vaginal estrogen acts like systemic hormone therapy, circulating through the body and carrying the same risks. Low-dose formulations keep blood estrogen levels quite low. With a 0.2 mg estradiol cream, serum estradiol peaks at about 80 pg/mL and returns toward baseline, whereas a tenfold higher dose (2.0 mg) sends serum estradiol soaring to over 500 pg/mL.⁸ The takeaway: dose matters enormously. Stick with the low-dose products your clinician prescribes, and systemic absorption stays minimal.

A large cohort study of nurses tracked vaginal estrogen users over many years and found no increased risk of heart attack, stroke, blood clots, invasive cancer, endometrial cancer, or hip fracture compared with non-users, after adjusting for a long list of health and lifestyle factors.⁹ That reassurance is especially relevant for women who took systemic hormone therapy off the table due to cardiovascular concerns but may still be good candidates for local treatment.

Vaginal DHEA (Prasterone)

If you prefer a hormonal approach that does not involve estrogen directly, vaginal DHEA is worth knowing about. DHEA (dehydroepiandrosterone) is a precursor hormone that your body converts locally into both estrogens and androgens right inside the vaginal tissue. Because the conversion happens at the site, serum hormone levels stay within the normal postmenopausal range.¹⁰ Sold under the brand name Intrarosa, it is inserted nightly as a vaginal suppository. Studies show it reverses dryness, pain, and tissue thinning rapidly. For some women, the androgen component provides an added benefit for sexual function that estrogen-only products do not match as strongly. The main drawback is the daily insertion schedule, which some people find cumbersome over time.

Ospemifene, an Oral Non-Estrogen Option

Ospemifene is a pill you take by mouth that acts on estrogen receptors selectively, meaning it behaves like estrogen in vaginal tissue but not in the breast or uterus. In a trial of over 600 women, it significantly improved vaginal cell composition, lowered vaginal pH, and reduced pain during sex compared with placebo, with differences showing up as early as four weeks.¹¹ Another randomized trial confirmed those same improvements for vaginal dryness specifically, with about a third of treated women meeting responder criteria at 12 weeks versus only 6% on placebo.¹²

Beyond the objective measures, sexual function scores improved across every domain tested, including desire, arousal, and pain, after 12 weeks on ospemifene.¹³ The most common side effect was hot flushes, reported by roughly 7% of participants. No serious drug-related adverse events occurred in the trials.

Ospemifene has a practical edge that shows up in real-world adherence data. In one comparative study, women on ospemifene reported adherence rates around 97%, compared with roughly 79% for local hormone therapy and 70% for vaginal moisturizers.¹⁴ Taking a daily pill is simply easier for many people than inserting a cream or tablet vaginally on a set schedule. This matters because atrophy is a chronic condition; stopping treatment usually means symptoms return.

Non-Hormonal Over-the-Counter Strategies

For women who cannot or prefer not to use any hormonal product, several effective options exist. The key distinction here is between moisturizers and lubricants. Moisturizers are applied regularly (typically a few times a week) to rehydrate vaginal tissue and keep it supple between sexual encounters. Lubricants are used during sex to reduce friction. You can use both, and you can layer them on top of hormonal treatments if those alone are not enough.¹⁵

Hyaluronic Acid Gels

Hyaluronic acid vaginal gels have emerged as the strongest non-hormonal contender. In clinical comparisons, hyaluronic acid gel matched estriol cream for dryness relief, with improvement rates around 84% and 89% respectively after ten applications, a difference that was not statistically significant.¹⁶ A separate study confirmed those findings and found similar rates of improvement for itching, burning, and pain during sex between hyaluronic acid and estriol.¹⁷

A randomized pilot trial comparing hyaluronic acid directly to vaginal estrogen found no clinically meaningful difference in overall vaginal symptom scores at 12 weeks.¹⁸ Another controlled trial found that hyaluronic acid cream actually outperformed conjugated estrogen cream on certain measures, including dryness, maturation index, and a composite symptom score, and it was the only group to show improvement in urinary incontinence.¹⁹ These are relatively small studies, and the evidence base for hyaluronic acid is not yet as deep as it is for estrogen. Still, for anyone who needs a hormone-free approach, it is the most promising option currently on shelves.

Lubricants for Comfortable Sex

During sex, a good lubricant can make the difference between pain and comfort. Lubricants are especially valuable for women who experience dryness and pain during penetration.²⁰ Water-based and silicone-based products are the two main categories. A crossover trial in breast cancer survivors, a group with particularly severe dryness, found no overall difference in total sexual discomfort between the two types, though a secondary analysis showed that pain during penetration improved more with the silicone-based product.²¹ Water-based lubricants dry out faster and may need reapplication, while silicone-based products last longer but can degrade silicone toys. Oil-based lubricants are another option but can weaken latex condoms and may irritate some people.

A practical tip: avoid products with glycerin, parabens, chlorhexidine, or high osmolality, all of which can irritate already-sensitive tissue. Look for products labeled “iso-osmotic” or check the ingredient list for simplicity.

Laser and Energy-Based Treatments

Fractional CO₂ laser therapy has generated a lot of attention as a non-hormonal in-office treatment. The laser creates tiny controlled injuries in the vaginal wall, stimulating the tissue to produce new collagen and improve blood flow. A study following women for 18 months after a course of three treatments found that vaginal health scores and most symptoms remained significantly improved well beyond the treatment period.²²

There is an important caveat. The FDA has cleared CO₂ laser devices for general soft-tissue procedures, including gynecological surgery, but it has not specifically evaluated or approved them for “vaginal rejuvenation” or treatment of atrophy symptoms.²³ The FDA has also issued warnings about marketing laser and radiofrequency devices for unapproved vaginal uses. That does not mean the laser is ineffective; it means the regulatory review process has not caught up with the clinical research. If you pursue this option, find a provider who uses it within the scope of existing clearances and who can walk you through the evidence honestly. Treatments typically involve three sessions spaced about a month apart, with maintenance sessions potentially needed annually. Cost is usually not covered by insurance.

The Vaginal Microbiome Connection

Healthy premenopausal vaginal tissue is dominated by Lactobacillus bacteria, which produce lactic acid and keep pH low. After menopause, as estrogen drops, Lactobacillus populations shrink and a more diverse array of bacteria moves in, raising pH and making the environment more hospitable to infections.²⁴ This shift has been described as a “menopause paradox” because greater microbial diversity is usually considered beneficial in other body sites like the gut, but in the vagina it signals a loss of the protective acid barrier.²⁵

This has naturally led to interest in vaginal probiotics. A systematic review of Lactobacillus-based probiotics for menopausal urogenital symptoms found mixed results. Intravaginal Lactobacillus showed some promise for preventing recurrent bladder infections in single-arm and cohort studies, but randomized controlled trials did not consistently beat antibiotics or placebo. Evidence for improving vaginal dryness, pH, or pain was limited and inconsistent, particularly for oral probiotics.²⁶ Probiotics may eventually play a supporting role, but they are not ready to stand alone as a prevention or treatment strategy for atrophy.

Pelvic Floor Training

Pelvic floor muscle exercises, commonly known as Kegels, are unlikely to reverse atrophy on their own, but they can improve blood flow to the area and help with some associated symptoms. A case study documented that 12 weeks of structured pelvic floor training reduced a patient’s vaginal dryness and pain during sex, and improved muscle tone and elasticity, though some objective signs of atrophy remained unchanged.²⁷ The evidence base here is thin, limited mostly to case reports rather than controlled trials. Still, pelvic floor work carries no risks, costs nothing, and can complement any other treatment you are using. Some physiotherapists specialize in pelvic health and can teach you proper technique, which matters more than people realize; many women who think they are doing Kegels correctly are actually bearing down instead of lifting.

What If You Have a History of Breast Cancer

Breast cancer survivors, especially those taking aromatase inhibitors, face some of the worst vaginal atrophy because these drugs suppress estrogen production aggressively. The question of whether low-dose vaginal estrogen is safe in this population is one of the most debated in menopause medicine. A meta-analysis found that after eight weeks of local hormonal treatment, serum estradiol levels did not change, and no significant increase in adverse effects was observed, concluding that vaginal estrogen in women with a breast cancer history does not appear to cause measurable systemic hormone absorption.²⁸ That said, many oncologists remain cautious, and the decision usually involves a conversation between you, your oncologist, and your gynecologist.

For women whose oncology team says no to any hormonal approach, non-ablative laser therapy is being explored as an alternative. A preliminary study in breast cancer survivors on aromatase inhibitors found significant improvement in vaginal health scores, pH, and pain at six months after treatment, with high patient satisfaction and no relevant side effects.²⁹ Hyaluronic acid gels, lubricants, and moisturizers remain safe baseline options for this group as well.

Sticking With Treatment Long Enough for It to Work

One of the biggest obstacles to preventing vaginal atrophy is not finding the right treatment but staying on it. Atrophy is chronic; the tissue does not regenerate permanently and then stop needing support. When you stop treatment, symptoms tend to return. Yet real-world prescription data shows that the vast majority of women who start with estrogen creams abandon them after only their first prescription, with the average treatment lasting just 44 to 48 days. Women who started with vaginal tablets fared better, averaging about 103 days, but even among them, over half discontinued within a year.³⁰

The messiness of vaginal creams is a frequently cited reason for stopping. Tablets and rings require less handling. Oral ospemifene, as mentioned earlier, had the highest adherence rates in the comparative study that tracked real-world use.¹⁴ If you have tried a vaginal product and found it too inconvenient, switching formulations or delivery methods may solve the problem more effectively than switching ingredients.

How to Build a Practical Prevention Plan

There is no single “best” approach because the best one is the one you will actually use consistently. For women in perimenopause who are starting to notice dryness but have no contraindication to hormones, low-dose vaginal estrogen or DHEA initiated early can prevent tissue from deteriorating in the first place. For women who cannot or choose not to use hormones, regular use of a hyaluronic acid vaginal gel two to three times a week, with a quality lubricant during sex, covers the most common symptoms. Adding pelvic floor exercises to either plan can improve muscle tone and blood flow in the area.

A few principles that apply across all approaches:

Start early: Treatment works better on tissue that has not yet fully atrophied. If you are in your late forties and noticing occasional dryness, that is the time to act.
Be consistent: Sporadic use of any product, hormonal or not, will not maintain results. Most effective regimens involve daily or every-other-day use during the initial weeks, tapering to two or three times weekly for maintenance.
Layer if needed: Using a moisturizer regularly does not prevent you from also using a lubricant during sex, or from adding a prescription product if symptoms worsen.
Reassess periodically: Your needs may change. A woman who starts with lubricant alone might benefit from adding hyaluronic acid a few years later, or from discussing vaginal estrogen with her doctor if non-hormonal options plateau.

Regular sexual activity, whether partnered or solo, also helps maintain vaginal health by promoting blood flow to the tissue. This is not a substitute for treatment if you are symptomatic, but it can complement whatever approach you choose and may slow the progression of atrophy.

Why So Many Women Go Untreated

Despite effective treatments being available, up to half or more of affected women never bring up their symptoms with a healthcare provider.² Some assume dryness and discomfort are just part of aging. Others worry about hormone safety based on headlines from the early 2000s that were primarily about systemic hormone therapy, a different product category with a different risk profile than low-dose vaginal estrogen. Clinicians, for their part, do not always ask about vaginal symptoms during routine visits. The result is a condition that has been called a “silent epidemic,” with millions of women enduring discomfort that effective, well-studied treatments could relieve. If something in this article sounds like what you are experiencing, bringing it up with your doctor is the most important step you can take. The treatments exist. The conversation just has to happen.